- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Optomed PLC (OPTOMED)
Optomed PLC stock price live, this page displays HE OPTOMED stock exchange data. View the OPTOMED premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Optomed PLC real time stock price chart below.
What Is the Optomed PLC Stock Price Today?
The Optomed PLC stock price today is 4.22.
What Is the Stock Symbol for Optomed PLC?
The stock symbol for Optomed PLC is ""OPTOMED.""
What Stock Exchange Does Optomed PLC Trade On?
Optomed PLC is listed and trades on the Helsinki stock exchange.
Is Optomed PLC a Good Stock to Buy?
Determining whether Optomed PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPTOMED quote. (ISIN: FI4000410881)
What Is the Optomed PLC Stock Price Today?
The Optomed PLC stock price today is 4.22.
What Is the Stock Symbol for Optomed PLC?
The stock symbol for Optomed PLC is ""OPTOMED.""
What Stock Exchange Does Optomed PLC Trade On?
Optomed PLC is listed and trades on the Helsinki stock exchange.
Is Optomed PLC a Good Stock to Buy?
Determining whether Optomed PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPTOMED quote. (ISIN: FI4000410881)
Helsinki
Currency in EUR
4.22
+0.10(+2.30%)
Real-time Data·
Fair Value
An estimate of a Optomed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.14
4.22
52 wk Range
3.10
6.40
OPTOMED Scorecard
Full Analysis
Stock price movements are quite volatile
OPTOMED is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Optomed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.144.22
52 wk Range
3.106.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OPTOMED Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Optomed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
5.38
Upside
+27.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Optomed PLC Company Profile
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, and Optomed Polaris brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands. The company provides Avenue AI, an AI streamlines eye specialists’ work and minimises screening costs; Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Flow, an eyecare management software; and Avenue Telemedicine, a remote analysis solution. In addition, it offers Cancer Screen, a screening process management software; Optomed RIS, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; Cephalometry, a powerful, flexible, and easy-to-use Windows software for orthodontics, oral and maxillofacial surgery; and Pathology PACS, which allows digital pathology images to be reviewed and shared. The company sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.
Compare OPTOMED to Peers and Sector
Metrics to compare | OPTOMED | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPTOMEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.0x | −3.7x | −0.5x | |
PEG Ratio | 0.64 | −0.05 | 0.00 | |
Price/Book | 3.7x | 2.2x | 2.6x | |
Price / LTM Sales | 5.3x | 2.2x | 3.2x | |
Upside (Analyst Target) | 30.8% | 28.9% | 41.9% | |
Fair Value Upside | Unlock | 3.3% | 4.3% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.38
(+27.37% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
-0.082 / -0.0853
Revenue / Forecast
4.01M / 3.66M
People Also Watch
FAQ
What Stock Exchange Does Optomed Trade On?
Optomed is listed and trades on the Helsinki Stock Exchange stock exchange.
What Is the Stock Symbol for Optomed?
The stock symbol for Optomed is "OPTOMED."
What Is the Optomed Market Cap?
As of today, Optomed market cap is 81.19M.
What Is Optomed's Earnings Per Share (TTM)?
The Optomed EPS (TTM) is -0.31.
When Is the Next Optomed Earnings Date?
Optomed will release its next earnings report on 02 Sept 2025.
From a Technical Analysis Perspective, Is OPTOMED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Optomed Stock Split?
Optomed has split 0 times.
How Many Employees Does Optomed Have?
Optomed has 118 employees.
What is the current trading status of Optomed (OPTOMED)?
As of 24 Jul 2025, Optomed (OPTOMED) is trading at a price of 4.22, with a previous close of 4.13. The stock has fluctuated within a day range of 4.14 to 4.22, while its 52-week range spans from 3.10 to 6.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.